
Yorimeth P 1500mcg/75mg Tablet SR
Marketer
Roseate Medicare
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Yorimeth P 1500mcg/75mg Tablet SR
CalmaNeu P 1500mcg/75mg Extended-Release Tablets are a prescription medication for neuropathic pain management. It works by regulating calcium channel function within nerve cells, reducing pain signals. This medication also offers neuroprotective effects, promoting nerve fiber health and repair of damaged nerve cells. CalmaNeu P 1500mcg/75mg Extended-Release Tablets are taken orally, with or without food, ideally before sleep. Consistent daily timing helps maintain stable blood levels. Follow your doctor's prescribed dosage and duration precisely, as this medication can be habit-forming. If a dose is missed, take it immediately upon remembering. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation should be avoided without consulting your physician. Common side effects may include upper respiratory infection, increased hunger, elevated mood, shaking, vision blurring, dry mouth, lightheadedness, and drowsiness. Avoid activities requiring alertness until the medication's effects are known. These side effects are generally mild and improve over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal thoughts to your doctor. Disclose all other medications you are using, as interactions may reduce CalmaNeu P's effectiveness or alter its action. Inform your doctor about pregnancy, pregnancy plans, or breastfeeding.
Uses of Yorimeth P 1500mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of Yorimeth P 1500mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Yorimeth P 1500mcg/75mg Sustained-Release Tablet can be consumed with or without food, though consistent timing is preferred.
Common Side effects of Yorimeth P 1500mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Yorimeth P 1500mcg/75mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Yorimeth P 1500mcg/75mg Extended-Release Tablet can be consumed with or without food, however, consistent daily timing is recommended.
How Yorimeth P 1500mcg/75mg Tablet SR works:
Yorimeth P, a sustained-release tablet containing 1500 mcg methylcobalamin and 75 mg pregabalin, offers dual-action pain relief. Methylcobalamin, a B vitamin, supports myelin sheath production, protecting and repairing nerve cells. Pregabalin, acting as an alpha-2-delta ligand, reduces pain signals by modulating neuronal calcium channels. This synergistic effect provides targeted relief from neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Yorimeth P 1500mcg/75mg sustained-release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Yorimeth P 1500mcg/75mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Yorimeth P 1500mcg/75mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Yorimeth P 1500mcg/75mg Extended-Release Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Yorimeth P 1500mcg/75mg sustained-release tablets cautiously. Dosage modification of Yorimeth P 1500mcg/75mg sustained-release tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Yorimeth P 1500mcg/75mg Tablet SR in patients with liver impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Yorimeth P 1500mcg/75mg Tablet SR :
Should you forget to take a Yorimeth P 1500mcg/75mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Yorimeth P 1500mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
